http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2505141-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70f1b701d26bef2d534c162c3611ac25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
filingDate 2003-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2225d583fa094d2d0dfcd5e96ea76fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d723ffb21b869df6a5df0d8e2de6be9
publicationDate 2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2505141-A1
titleOfInvention Chaperonin 10 immunosuppression
abstract The invention is directed to the use of cpn10 in transplantation and particularly to treatment and/or prevention of graft versus host disease. The invention provides a method of administration of cpn10 to a donor and/or recipient animal or cells, tissues or organs derived from the donor, although in a particularly advantageous form treatment of both the donor and recipient animal. The method may further include the administration to the donor and/or recipient animal at least one other immunosuppressive agent to prevent or alleviate graft versus host disease.
priorityDate 2002-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9W6X3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446541
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31233
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445643
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426352332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281078
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO65282
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ96539
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5DC69
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153274811
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34893
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54J68
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26772
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507158
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61604

Total number of triples: 43.